FABP4+ prostate cancer cells were significantly more invasive as compared to cells treated with a FABP inhibitor, and treatment with a fatty acid, oleic acid, was able to further enhance the invasiveness of FABP4+ prostate cancer cells [63]. This evidence concerns the gene FABP4 and prostate carcinoma.